Data generation needs careful consideration

摘要

Craig Stobie of Domino Printing Sciences examines the thinking behind how the vast amounts of data acquired under the auspices of the FMD will be collected, stored and interrogated - and why For most pharmaceutical manufacturers the past couple of years should rightly have been about building the correct hardware eco-system and establishing the operating landscape to achieve a consistently high standard of robust marking to support item-level serialisation ahead of the implementation of the EU Falsified Medicines Directive (FMD).